The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients

NCT03292861 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Transplantation

Interventions

DRUG: Thymoglobulin
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Sirolimus
DRUG: Corticosteroids

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]